Trending Topic

Illustration of the thought processes in the brain
13 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3% of the population, with incidence on the rise due to the increased utilization of neuro-imaging for diverse objectives.1,2 The average risk of rupture for unruptured IA is estimated to vary from 0.3% to exceeding 15% per 5 years.3 Ruptured IA is the primary aetiology of […]

Georg Ebersbach, MDS 2020 – Opicapone’s Potential as a First-line Adjunctive Therapy for Motor Fluctuations of Parkinson’s Disease

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 23rd 2020

Georg Ebersbach (Movement Disorders Clinic, Beelitz-Heilstaetten, Beelitz, Germany) kindly took the time to talk us through the findings of his presentation entitled: Opicapone’s added benefit as a first-line adjunctive therapy to levodopa and when used promptly in the motor fluctuations spectrum of Parkinson’s disease: a post-hoc analysis of BIPARK-I and II.

ClinicalTrials.gov identifiers for the two large multinational trials included in this post-hoc analysis, that previously demonstrated efficacy and safety of opicapone for end-of-dose motor fluctuations in Parkinson’s disease: NCT01568073 and NCT01227655, respectively.

Questions
1. What impact do motor fluctuations have on patients with Parkinson’s disease (PD)? (0:06)
2. Could you give us a brief overview of the main findings of the BIPARK-I and II studies supporting the use of opicapone in PD? (0:47)
3. What was the rationale for the post-hoc analysis you presented? (1:54)
4. What were the findings of this analysis? (2:24)
5. What are the implications of these findings in terms of the optimum use of opicapone in routine clinical practice? (3:35)

Disclosures: Prof. Ebersbach reports receiving honoraria for lectures and advisory board activities from BIAL, the manufacturer of opicapone.

Support: Interview and filming supported by Touch Medical Media.

Filmed as a highlight of the International Parkinson and Movement Disorder Society MDS Virtual Congress 2020.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup